Technologie de la santé
Entreprises Autrichiennes développant des technologies de santé
Le développement de dispositifs médicaux, de plateformes de diagnostic et de logiciels de santé définit le secteur des technologies de santé. Les délais d’approbation réglementaire et les modèles de remboursement Medicare en évolution injectent constamment de la liquidité dans ces actions. Actuellement, Novo Nordisk A/S Class B domine le volume d'échanges, tandis que Becton, Dickinson and Company affiche la meilleure performance sur 24 heures. Le tableau ci-dessous organise des données techniques et fondamentales essentielles.
Symbole | Capitalisation boursière | Prix | Chg % | Vol | Vol Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYCEli Lilly and Company | 1,19 T EUR | 1 222,4 EUR | −2,71% | 0 | 0,00 | 45,49 | 26,87 EUR | +55,94% | 0,47% | Strong Buy |
 JNJJohnson & Johnson | 592,45 B EUR | 244,80 EUR | −0,59% | 5 | 0,12 | 42,07 | 5,82 EUR | −34,10% | 1,91% | Buy |
 ABBVAbbVie, Inc. | 464,16 B EUR | 259,6 EUR | −1,29% | 0 | 0,00 | 50,61 | 5,13 EUR | +354,14% | 2,35% | Buy |
 ROGPRoche Holding Ltd | 343,88 B EUR | 419 EUR | −1,87% | 0 | 0,00 | 25,24 | 16,60 EUR | +32,10% | 2,48% | Buy |
| ROGHRoche Holding Ltd | 343,88 B EUR | 427,0 EUR | −1,93% | 0 | 0,00 | 25,72 | 16,60 EUR | +32,10% | 2,69% | Buy |
 MRKMerck & Co., Inc. | 330,4 B EUR | 131,62 EUR | −1,78% | 0 | 0,00 | 152,27 | 0,86 EUR | −86,58% | 2,26% | Buy |
 NOVNNovartis AG | 267,8 B EUR | 143,02 EUR | −1,72% | 0 | 0,00 | 32,64 | 4,38 EUR | −33,91% | 2,76% | Neutre |
 TMOFThermo Fisher Scientific Inc. | 233,03 B EUR | 618,4 EUR | −0,29% | 0 | 0,00 | 36,96 | 16,73 EUR | +13,44% | 0,26% | Buy |
 AMGNAmgen Inc. | 230,4 B EUR | 413,60 EUR | −0,86% | 0 | 0,00 | 27,18 | 15,22 EUR | +38,07% | 2,08% | Neutre |
 GILDGilead Sciences, Inc. | 192,75 B EUR | 150,26 EUR | −1,83% | 25 | 0,28 | — | −2,78 EUR | −150,52% | 1,86% | Buy |
 ABTAbbott Laboratories | 178,02 B EUR | 99,56 EUR | −1,91% | 0 | 0,00 | 41,64 | 2,39 EUR | −64,81% | 2,18% | Buy |
 NNO2Novo Nordisk A/S Class B | 168,68 B EUR | 36,145 EUR | +0,25% | 2,9 K | 0,50 | 10,63 | 3,40 EUR | +9,26% | 4,10% | Neutre |
 PFEPfizer Inc. | 156,31 B EUR | 26,315 EUR | −3,11% | 157 | 0,11 | 42,64 | 0,62 EUR | −57,78% | 5,59% | Neutre |
 ISRGIntuitive Surgical, Inc. | 148,84 B EUR | 410,95 EUR | −4,69% | 0 | 0,00 | 56,33 | 7,30 EUR | +13,32% | 0,00% | Buy |
 DHRCDanaher Corporation | 147,21 B EUR | 204,6 EUR | −0,49% | 0 | 0,00 | 37,95 | 5,39 EUR | +30,20% | 0,65% | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 123,98 B EUR | 489,90 EUR | +1,52% | 0 | 0,00 | 35,70 | 13,72 EUR | +13,49% | 0,00% | Buy |
 MDTMedtronic Plc | 119,58 B EUR | 91,84 EUR | −1,18% | 100 | 0,91 | 26,05 | 3,53 EUR | +11,12% | 2,72% | Buy |
 BMYSBristol-Myers Squibb Company | 116,86 B EUR | 56,03 EUR | −1,67% | 0 | 0,00 | 14,06 | 3,98 EUR | +57,85% | 3,93% | Buy |
 SYKStryker Corporation | 115,16 B EUR | 292,6 EUR | −5,03% | 0 | 0,00 | 35,31 | 8,29 EUR | +27,68% | 1,04% | Buy |
 SANOSanofi SA | 100,88 B EUR | 80,98 EUR | −6,20% | 2 | 0,00 | 24,32 | 3,33 EUR | −35,60% | 4,90% | Buy |
 MRNAModerna, Inc. | 91,88 B EUR | 234,25 EUR | +6,65% | 133 | 0,69 | — | −6,99 EUR | −9,55% | 0,00% | Neutre |
 EIEssilorLuxottica SA | 87,56 B EUR | 193,85 EUR | +1,31% | 166 | 0,16 | 36,22 | 5,35 EUR | +3,83% | 2,12% | Buy |
 REGNRegeneron Pharmaceuticals, Inc. | 85,73 B EUR | 807,3 EUR | −1,67% | 0 | 0,00 | 20,19 | 39,99 EUR | +12,33% | 0,40% | Buy |
 MRCKMerck KGaA | 65,41 B EUR | 145,00 EUR | −4,98% | 0 | 0,00 | 26,60 | 5,45 EUR | −17,22% | 1,46% | Buy |
 BSXCBoston Scientific Corporation | 59,15 B EUR | 38,775 EUR | −2,82% | 1 | 0,01 | 18,60 | 2,09 EUR | +30,86% | 0,00% | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 59,1 B EUR | 37,42 EUR | −3,16% | 0 | — | 318,28 | 0,12 EUR | +2,11% | 3,07% | Buy |
 UCBUCB S.A. | 53,69 B EUR | 282,4 EUR | −1,05% | 0 | 0,00 | 24,98 | 11,31 EUR | +64,98% | 0,36% | Buy |
 BAYNBayer AG | 53,29 B EUR | 54,50 EUR | −3,16% | 967 | 0,29 | — | −1,77 EUR | +49,15% | 0,20% | Buy |
 ARGXargenx SE | 51,25 B EUR | 796,2 EUR | −3,72% | 0 | 0,00 | 35,36 | 22,51 EUR | +24,40% | 0,00% | Strong Buy |
 EWLSEdwards Lifesciences Corporation | 51,01 B EUR | 90,30 EUR | +0,49% | 0 | 0,00 | 61,20 | 1,48 EUR | +18,67% | 0,00% | Buy |
 BDXBecton, Dickinson and Company | 50,75 B EUR | 191,70 EUR | +8,34% | 0 | 0,00 | 66,04 | 2,90 EUR | −38,51% | 2,01% | Buy |
 SHLSiemens Healthineers AG | 50,04 B EUR | 43,96 EUR | −0,14% | 0 | 0,00 | 22,27 | 1,97 EUR | +2,35% | 2,23% | Buy |
 GALDGalderma Group AG | 49,43 B EUR | 210 EUR | −1,87% | 0 | 0,00 | 66,76 | 3,15 EUR | +113,32% | 0,18% | Buy |
 LONNLonza Group AG | 49,13 B EUR | 715,6 EUR | −2,00% | 0 | 0,00 | — | −1,68 EUR | −115,37% | 0,76% | Buy |
 IDXXIDEXX Laboratories, Inc. | 49,02 B EUR | 604,8 EUR | −3,48% | 0 | 0,00 | 46,18 | 13,10 EUR | +21,83% | 0,00% | Buy |
 AGILAgilent Technologies, Inc. | 44,49 B EUR | 156,20 EUR | +0,19% | 0 | 0,00 | 35,43 | 4,41 EUR | +18,01% | 0,58% | Buy |
 WTRSWaters Corporation | 40,92 B EUR | 413,8 EUR | +1,32% | 0 | 0,00 | 201,35 | 2,06 EUR | −77,83% | 0,00% | Buy |
 SDZSandoz Group Ltd | 39,38 B EUR | 90,28 EUR | −0,62% | 0 | 0,00 | 70,79 | 1,28 EUR | +169,78% | 0,97% | Neutre |
 IQVHIQVIA Holdings Inc | 38,72 B EUR | 241,9 EUR | +2,28% | 0 | 0,00 | 33,30 | 7,26 EUR | +17,03% | 0,00% | Strong Buy |
 ALCAlcon AG | 34,46 B EUR | 66,46 EUR | −2,69% | 0 | — | 59,18 | 1,12 EUR | −44,23% | 0,44% | Buy |
 BIIBBiogen Inc. | 33,5 B EUR | 222,00 EUR | −1,07% | 0 | 0,00 | 107,66 | 2,06 EUR | −77,93% | 0,00% | Buy |
 ZOTSZoetis, Inc. Class A | 32,83 B EUR | 71,44 EUR | −9,02% | 0 | 0,00 | 13,42 | 5,32 EUR | +7,88% | 2,38% | Neutre |
 MTDMettler-Toledo International Inc. | 30,75 B EUR | 1 560 EUR | +3,04% | 0 | 0,00 | 40,10 | 38,90 EUR | +16,08% | 0,00% | Neutre |
 ILMNIllumina, Inc. | 30,51 B EUR | 189,98 EUR | −6,02% | 0 | 0,00 | 36,98 | 5,14 EUR | +35,08% | 0,00% | Buy |
 RMDResMed Inc. | 30,13 B EUR | 210,7 EUR | −3,70% | 0 | 0,00 | 21,74 | 9,69 EUR | +16,41% | 1,02% | Buy |
 DXCMDexCom, Inc. | 29,39 B EUR | 72,4 EUR | −9,95% | 0 | — | 32,15 | 2,25 EUR | +47,09% | 0,00% | Strong Buy |
 GMABGenmab A/S | 28,53 B EUR | 472,9 EUR | −2,27% | 0 | 0,00 | 43,71 | 10,82 EUR | −40,96% | 0,00% | Buy |
 DIMSartorius Stedim Biotech SA | 21,76 B EUR | 222,6 EUR | −2,54% | 0 | — | 66,87 | 3,33 EUR | +22,74% | 0,31% | Strong Buy |
 VTRSViatris, Inc. | 19,66 B EUR | 17,372 EUR | +1,56% | 0 | 0,00 | — | −0,31 EUR | +87,33% | 2,50% | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 19,22 B EUR | 141,20 EUR | −5,36% | 0 | 0,00 | 8,08 | 17,48 EUR | +8 430,94% | 0,00% | Buy |
 ZBHZimmer Biomet Holdings, Inc. | 18,71 B EUR | 95,00 EUR | −4,08% | 0 | 0,00 | 27,26 | 3,48 EUR | +1,19% | 0,87% | Neutre |
 STMNStraumann Holding AG | 18,66 B EUR | 113 EUR | −2,59% | 0 | 0,00 | 45,09 | 2,51 EUR | −4,77% | 0,93% | Buy |
 SOONSonova Holding AG | 18,17 B EUR | 311,1 EUR | −2,45% | 0 | — | 39,78 | 7,82 EUR | −17,15% | 1,62% | Neutre |
| SATGSartorius AG | 17,83 B EUR | 223,5 EUR | −3,25% | 0 | — | 70,67 | 3,16 EUR | +63,32% | 0,32% | Buy |
 COLOColoplast A/S Class B | 15,69 B EUR | 68,14 EUR | −2,18% | 0 | 0,00 | 37,43 | 1,82 EUR | −15,56% | 4,40% | Neutre |
 IPNIpsen SA | 12,89 B EUR | 154,0 EUR | −2,72% | 0 | 0,00 | 24,92 | 6,18 EUR | +15,12% | 1,03% | Neutre |
 BAXBaxter International Inc. | 12,21 B EUR | 22,85 EUR | −5,03% | 0 | 0,00 | — | −1,22 EUR | −174,16% | 0,15% | Neutre |
 BIMbioMerieux SA | 11,53 B EUR | 92,25 EUR | −3,25% | 0 | — | 23,65 | 3,90 EUR | +22,76% | 1,00% | Neutre |
 RECRecordati S.p.A. | 10,96 B EUR | 53,05 EUR | −0,28% | 0 | — | 22,29 | 2,38 EUR | +22,24% | 2,52% | Neutre |
 ALGNAlign Technology, Inc. | 10,43 B EUR | 146,25 EUR | −1,25% | 0 | — | 24,08 | 6,07 EUR | +38,11% | 0,00% | Buy |
 DEMADemant A/S | 10,27 B EUR | 50,50 EUR | −0,20% | 0 | — | 49,08 | 1,03 EUR | −28,80% | 0,00% | Buy |
 BMRNBioMarin Pharmaceutical Inc. | 9,86 B EUR | 49,98 EUR | −1,50% | 4 | 0,01 | — | −0,09 EUR | −104,02% | 0,00% | Buy |
 AVTRAvantor, Inc. | 9,45 B EUR | 13,810 EUR | −0,40% | 0 | — | 31,54 | 0,44 EUR | — | 0,00% | Neutre |
 QGE4QIAGEN NV | 9,35 B EUR | 45,2 EUR | −0,44% | 2 | 0,05 | 26,22 | 1,72 EUR | +12,91% | 0,69% | Neutre |
 KRKGKrka, d. d., Novo mesto | 7,73 B EUR | 247,5 EUR | −0,60% | 0 | — | 17,98 | 13,77 EUR | +10,70% | 3,67% | Buy |
 ALKBALK-abello A/S Class B | 7,24 B EUR | 32,52 EUR | −1,63% | 0 | — | 39,83 | 0,82 EUR | +35,40% | 0,66% | Strong Buy |
 LUNAH. Lundbeck A/S Class A | 7,13 B EUR | 6,92 EUR | +1,17% | 0 | 0,00 | 13,26 | 0,52 EUR | +11,06% | 2,27% | Pas de notation |
| LUNBH. Lundbeck A/S Class B | 7,13 B EUR | 7,500 EUR | +0,47% | 0 | 0,00 | 14,37 | 0,52 EUR | +11,06% | 2,10% | Buy |
 ABVXAbivax SA | 6,96 B EUR | 75,65 EUR | −6,83% | 3 | 0,75 | — | −5,23 EUR | −59,53% | 0,00% | Strong Buy |
 GRFGrifols, S.A. Class A | 6,67 B EUR | 10,995 EUR | −3,00% | 0 | — | 16,54 | 0,66 EUR | +51,93% | 1,68% | Buy |
 DIASDiaSorin S.p.A. | 4,43 B EUR | 81,56 EUR | −1,43% | 0 | 0,00 | 30,85 | 2,64 EUR | −23,38% | 1,58% | Neutre |
 SFZNSiegfried Holding AG | 3,68 B EUR | 78,50 EUR | −2,91% | 0 | — | 18,53 | 4,24 EUR | +12,47% | 0,53% | Buy |
 1SXPSCHOTT Pharma AG & Co. KGaA | 3,52 B EUR | 21,65 EUR | −5,04% | 0 | — | 23,88 | 0,91 EUR | −7,01% | 0,77% | Buy |
 FIEFielmann Group AG | 3,48 B EUR | 42,80 EUR | +0,23% | 0 | — | 16,97 | 2,52 EUR | +24,89% | 3,38% | Buy |
 TECNTecan Group AG | 3,42 B EUR | 282,0 EUR | −3,56% | 0 | 0,00 | — | −9,92 EUR | −287,20% | 1,23% | Buy |
 ROVILaboratorios Farmaceuticos Rovi, S.A. | 3,22 B EUR | 67,65 EUR | −2,87% | 0 | — | 18,68 | 3,62 EUR | +39,34% | 1,22% | Buy |
 AFXCarl Zeiss Meditec AG | 3,2 B EUR | 33,90 EUR | −6,20% | 0 | — | 31,28 | 1,08 EUR | −38,81% | 1,54% | Sell |
 OBCKOttobock SE & Co. KGaA | 3,1 B EUR | 47,60 EUR | −2,76% | 0 | 0,00 | 23,69 | 2,01 EUR | — | 2,00% | Strong Buy |
 AMBUAmbu A/S Class B | 3,04 B EUR | 11,74 EUR | −2,33% | 0 | — | 46,05 | 0,25 EUR | +41,47% | 0,48% | Neutre |
 BAVABavarian Nordic A/S | 2,61 B EUR | 32,50 EUR | −1,28% | 1 | — | 12,18 | 2,67 EUR | +9,77% | 0,00% | Strong Buy |
 ALMAlmirall SA | 2,42 B EUR | 11,10 EUR | −1,77% | 0 | — | 40,51 | 0,27 EUR | — | 1,36% | Buy |
 ZEALZealand Pharma A/S | 2,1 B EUR | 31,20 EUR | −1,61% | 0 | 0,00 | 6,05 | 5,16 EUR | −58,53% | 0,00% | Buy |
 LKFTLakefront Biotherapeutics | 1,96 B EUR | 29,08 EUR | −4,22% | 0 | — | 3,21 | 9,05 EUR | — | 0,00% | Buy |
 DMPDermapharm Holding SE | 1,93 B EUR | 37,85 EUR | −2,70% | 0 | — | 13,72 | 2,76 EUR | +38,58% | 2,26% | Buy |
 XRAYDENTSPLY SIRONA, Inc. | 1,89 B EUR | 8,572 EUR | −6,07% | 0 | 0,00 | — | −2,40 EUR | +40,51% | 3,00% | Neutre |
 DRW8Draegerwerk AG & Co. KGaA | 1,72 B EUR | 77,0 EUR | −2,78% | 0 | — | 8,51 | 9,04 EUR | +40,18% | 2,80% | Buy |
 NVAXNovavax, Inc. | 1,56 B EUR | 9,50 EUR | +2,26% | 5 | 0,02 | — | −1,33 EUR | −169,59% | 0,00% | Buy |
 PHMPharma Mar SA | 1,19 B EUR | 66,85 EUR | 0,00% | 0 | — | 17,06 | 3,92 EUR | +102,78% | 1,21% | Buy |
 COPNCosmo N.V. | 1,1 B EUR | 61,5 EUR | −5,53% | 7 | 0,69 | — | −0,38 EUR | −111,41% | 3,22% | Strong Buy |
 EUZGEckert & Ziegler SE | 876,04 M EUR | 13,59 EUR | −4,63% | 0 | — | 17,18 | 0,79 EUR | +35,27% | 1,57% | Strong Buy |
 VLAValneva SE | 481,73 M EUR | 2,467 EUR | −4,19% | 538 | 0,74 | — | −0,90 EUR | −117,39% | 0,00% | Strong Buy |
 FYBFormycon AG | 330,13 M EUR | 14,08 EUR | −21,69% | 0 | 0,00 | — | −1,42 EUR | +85,20% | 0,00% | Strong Buy |
 SBSGSTRATEC SE | 310,58 M EUR | 25,05 EUR | −3,28% | 0 | — | — | −0,03 EUR | −103,25% | 2,35% | Buy |
 HPHAHeidelberg Pharma AG | 94,04 M EUR | 2,08 EUR | +2,46% | 0 | 0,00 | — | −0,64 EUR | −13,94% | 0,00% | Strong Buy |
 PTPNPentixapharm Holding AG | 67,66 M EUR | 1,905 EUR | −4,75% | 355 | 975 816 569 651 200,00 | — | — | — | 0,00% | Strong Buy |
 GHCGallmetzer Healthcare SpA | — | 3,40 EUR | 0,00% | 0 | 0,00 | — | — | — | — | Strong Buy |
 BIOBiogena Group Invest AG | — | 4,86 EUR | −0,41% | 297 | 0,19 | — | — | — | — | Pas de notation |